PharmaShots | Incisive News in 3 Shots

Subscribe Now

STYLE Study

Celgene Reports Otezla (apremilast) Achieve 1EP in P-III STYLE Study to Treat Moderate-to-Severe Scalp Psoriasis

Celgene Reports Otezla (apremilast) Achieve 1EP in P-III STYLE Study to Treat Moderate-to-Severe Scalp Psoriasis

October 9, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us